Metabolomic analysis to predict the onset and severity of necrotizing enterocolitis.
Humans
Enterocolitis, Necrotizing
/ urine
Infant, Newborn
Prospective Studies
Metabolomics
Biomarkers
/ urine
Female
Male
Infant, Premature
/ urine
Carnitine
/ analogs & derivatives
Case-Control Studies
Intestinal Perforation
/ urine
Severity of Illness Index
Infant, Premature, Diseases
/ urine
Gestational Age
Biomarker
Mass-spectrometry
Metabolome
Necrotizing enterocolitis
Preterm neonate
Journal
BMC gastroenterology
ISSN: 1471-230X
Titre abrégé: BMC Gastroenterol
Pays: England
ID NLM: 100968547
Informations de publication
Date de publication:
26 Oct 2024
26 Oct 2024
Historique:
received:
13
07
2024
accepted:
08
10
2024
medline:
26
10
2024
pubmed:
26
10
2024
entrez:
25
10
2024
Statut:
epublish
Résumé
Necrotizing enterocolitis (NEC) is the most devastating gastrointestinal (GI) emergency in preterm neonates. Untargeted metabolomics may allow the identification of biomarkers involved in NEC pathophysiology. We conducted a prospective study including preterm infants born at < 34 gestational weeks (GWs) whose urine was longitudinally collected at birth (< 48 h, T0) and at 14 (T1) and 28 days (T2). Neonates were followed for their development of NEC, spontaneous intestinal perforation (SIP), or other GI conditions and compared to those of matched healthy controls. Urine samples were investigated by untargeted metabolomic analysis based on mass-spectrometry. Thirty-five patients with NEC, 5 patients with SIP, 14 patients with other GI diseases and 113 controls were enrolled and selected for metabolomic analysis on the basis of their clinical characteristics and available samples. Considering urine samples at T0, the one-class classification approach was able to correctly classify 16/20 subjects (80%) who developed NEC, 3/3 (100%) who developed SIP and 5/7 subjects (71.4%) with other GI pathologies as not belonging to the control group. Neonates with surgical NEC had higher N-acetylaspartic acid, butyrylcarnitine and propionylcarnitine levels than did those with medical NEC. Considering the time evolution of the urinary metabolome, the NEC and control groups showed differences independently of the time point. The urinary metabolome is closely associated with the underlying GI disease from birth. Urinary metabolic features characterize NEC patients from healthy controls until 28 days of life. The early urinary metabolome has the potential to predict surgical NEC. Future studies are needed to validate our results.
Sections du résumé
BACKGROUND
BACKGROUND
Necrotizing enterocolitis (NEC) is the most devastating gastrointestinal (GI) emergency in preterm neonates. Untargeted metabolomics may allow the identification of biomarkers involved in NEC pathophysiology.
METHODS
METHODS
We conducted a prospective study including preterm infants born at < 34 gestational weeks (GWs) whose urine was longitudinally collected at birth (< 48 h, T0) and at 14 (T1) and 28 days (T2). Neonates were followed for their development of NEC, spontaneous intestinal perforation (SIP), or other GI conditions and compared to those of matched healthy controls. Urine samples were investigated by untargeted metabolomic analysis based on mass-spectrometry.
RESULTS
RESULTS
Thirty-five patients with NEC, 5 patients with SIP, 14 patients with other GI diseases and 113 controls were enrolled and selected for metabolomic analysis on the basis of their clinical characteristics and available samples. Considering urine samples at T0, the one-class classification approach was able to correctly classify 16/20 subjects (80%) who developed NEC, 3/3 (100%) who developed SIP and 5/7 subjects (71.4%) with other GI pathologies as not belonging to the control group. Neonates with surgical NEC had higher N-acetylaspartic acid, butyrylcarnitine and propionylcarnitine levels than did those with medical NEC. Considering the time evolution of the urinary metabolome, the NEC and control groups showed differences independently of the time point.
CONCLUSIONS
CONCLUSIONS
The urinary metabolome is closely associated with the underlying GI disease from birth. Urinary metabolic features characterize NEC patients from healthy controls until 28 days of life. The early urinary metabolome has the potential to predict surgical NEC. Future studies are needed to validate our results.
Identifiants
pubmed: 39455932
doi: 10.1186/s12876-024-03453-y
pii: 10.1186/s12876-024-03453-y
doi:
Substances chimiques
Biomarkers
0
Carnitine
S7UI8SM58A
butyrylcarnitine
25576-40-3
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
380Informations de copyright
© 2024. The Author(s).
Références
Alsaied A, Islam N, Thalib L. Global incidence of necrotizing enterocolitis: a systematic review and meta-analysis. BMC Pediatr. 2020;20(1):344.
pubmed: 32660457
pmcid: 7359006
doi: 10.1186/s12887-020-02231-5
Han SM, Hong CR, Knell J, Edwards EM, Morrow KA, Soll RF, et al. Trends in incidence and outcomes of necrotizing enterocolitis over the last 12 years: a multicenter cohort analysis. J Pediatr Surg. 2020;55(6):998–1001.
pubmed: 32173122
doi: 10.1016/j.jpedsurg.2020.02.046
Jones IH, Hall NJ. Contemporary outcomes for infants with necrotizing enterocolitis—a systematic review. J Pediatr. 2020;220:86–92.e3.
pubmed: 31982088
doi: 10.1016/j.jpeds.2019.11.011
Bazacliu C, Neu J. Necrotizing enterocolitis: long term complications. Curr Pediatr Rev. 2019;15(2):115–24.
pubmed: 30864508
doi: 10.2174/1573396315666190312093119
Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978;187(1):1–7.
pubmed: 413500
pmcid: 1396409
doi: 10.1097/00000658-197801000-00001
Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am. 1986;33(1):179–201.
pubmed: 3081865
pmcid: 7131118
doi: 10.1016/S0031-3955(16)34975-6
Patel RM, Ferguson J, McElroy SJ, Khashu M, Caplan MS. Defining necrotizing enterocolitis: current difficulties and future opportunities. Pediatr Res. 2020;88:10–5. Springer Nature.
pubmed: 32855506
pmcid: 8096612
doi: 10.1038/s41390-020-1074-4
Culbreath K, Keefe G, Edwards EM, Morrow KA, Soll RF, Jaksic T, et al. Morbidity associated with laparotomy-confirmed spontaneous intestinal perforation: a prospective multicenter analysis. J Pediatr Surg. 2022;57(6):981–5.
pubmed: 35287964
doi: 10.1016/j.jpedsurg.2022.01.058
Berrington J, Embleton ND. Discriminating necrotising enterocolitis and focal intestinal perforation. Arch Dis Child Fetal Neonatal Ed. 2022;107(3):336–9.
pubmed: 34257102
doi: 10.1136/archdischild-2020-321429
Smith K, Folaranmi SE, Goel N. Intestinal obstruction and ileus in the newborn. Paediatr Child Health. 2022;32(1):7–12.
doi: 10.1016/j.paed.2021.10.003
D’Angelo G, Impellizzeri P, Marseglia L, Montalto AS, Russo T, Salamone I, et al. Current status of laboratory and imaging diagnosis of neonatal necrotizing enterocolitis. Ital J Pediatr. 2018;44(1):84.
pubmed: 30045775
pmcid: 6060553
doi: 10.1186/s13052-018-0528-3
Pammi M, De Plaen IG, Maheshwari A. Recent advances in necrotizing enterocolitis research: strategies for implementation in clinical practice. Clin Perinatol. 2020;47:383–97. W.B. Saunders.
pubmed: 32439118
pmcid: 7245582
doi: 10.1016/j.clp.2020.02.011
Howarth C, Banerjee J, Eaton S, Aladangady N. Biomarkers of gut injury in neonates – where are we in predicting necrotising enterocolitis? Front Pediatr. 2022;10:1048322.
pubmed: 36518779
pmcid: 9742605
doi: 10.3389/fped.2022.1048322
Terrin G, Stronati L, Cucchiara S, De Curtis M. Serum markers of necrotizing enterocolitis: a systematic review. J Pediatr Gastroenterol Nutr. 2017;65(6):e120–32.
pubmed: 28379923
doi: 10.1097/MPG.0000000000001588
Nicholson JK, Wilson ID. Understanding “Global” systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Discov. 2003;2(8):668–76.
pubmed: 12904817
doi: 10.1038/nrd1157
Carraro S, Giordano G, Reniero F, Perilongo G, Baraldi E. Metabolomics: a new frontier for research in pediatrics. J Pediatr. 2009;154(5):638–44.
pubmed: 19364557
doi: 10.1016/j.jpeds.2009.01.014
Shrestha B. Single-cell metabolomics by mass spectrometry. 2020. p. 1–8.
Frédérich M, Pirotte B, Fillet M, de Tullio P. Metabolomics as a challenging approach for medicinal chemistry and personalized medicine. J Med Chem. 2016;59(19):8649–66.
pubmed: 27295417
doi: 10.1021/acs.jmedchem.5b01335
Dessì A, Pintus R, Marras S, Cesare Marincola F, De Magistris A, Fanos V. Metabolomics in necrotizing enterocolitis: the state of the art. Expert Rev Mol Diagn. 2016;16(10):1053–8.
pubmed: 27403597
doi: 10.1080/14737159.2016.1211933
Moschino L, Verlato G, Duci M, Cavicchiolo ME, Guiducci S, Stocchero M, et al. The metabolome and the gut microbiota for the prediction of necrotizing enterocolitis and spontaneous intestinal perforation: a systematic review. Nutrients. 2022;14(18):3859.
pubmed: 36145235
pmcid: 9506026
doi: 10.3390/nu14183859
Stewart CJ, Embleton ND, Marrs ECL, Smith DP, Nelson A, Abdulkadir B, et al. Temporal bacterial and metabolic development of the preterm gut reveals specific signatures in health and disease. Microbiome. 2016;4(1):67.
pubmed: 28034304
pmcid: 5200962
doi: 10.1186/s40168-016-0216-8
Rusconi B, Jiang X, Sidhu R, Ory DS, Warner BB, Tarr PI. Gut sphingolipid composition as a prelude to necrotizing enterocolitis. Sci Rep. 2018;8(1):10984.
pubmed: 30030452
pmcid: 6054655
doi: 10.1038/s41598-018-28862-4
Morrow AL, Lagomarcino AJ, Schibler KR, Taft DH, Yu Z, Wang B, et al. Early microbial and metabolomic signatures predict later onset of necrotizing enterocolitis in preterm infants. Microbiome. 2013;1(1):13.
pubmed: 24450576
pmcid: 3971624
doi: 10.1186/2049-2618-1-13
Thomaidou A, Chatziioannou AC, Deda O, Benaki D, Gika H, Mikros E, et al. A pilot case-control study of urine metabolomics in preterm neonates with necrotizing enterocolitis. J Chromatogr B Analyt Technol Biomed Life Sci. 2019;1117:10–21.
pubmed: 30991202
doi: 10.1016/j.jchromb.2019.04.019
Picaud JC, De Magistris A, Mussap M, Corbu S, Dessì A, Noto A, et al. Urine NMR metabolomics profile of preterm infants with necrotizing enterocolitis over the first two months of life: a pilot longitudinal case-control study. Front Mol Biosci. 2021;8:680159.
pubmed: 34212004
pmcid: 8239193
doi: 10.3389/fmolb.2021.680159
Bosco A, Piu C, Picciau ME, Pintus R, Fanos V, Dessì A. Metabolomics in NEC: an updated review. Metabolites. 2023;14(1):14.
pubmed: 38248817
pmcid: 10821135
doi: 10.3390/metabo14010014
Thomaidou A, Deda O, Begou O, Lioupi A, Kontou A, Gika H, et al. A Prospective, case-control study of serum metabolomics in neonates with late-onset sepsis and necrotizing enterocolitis. J Clin Med. 2022;11(18):5270.
pubmed: 36142917
pmcid: 9505627
doi: 10.3390/jcm11185270
Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med. 2011;364(3):255–64 Available from: http://www.nejm.org/doi/abs/10.1056/NEJMra1005408 .
pubmed: 21247316
pmcid: 3628622
doi: 10.1056/NEJMra1005408
Moschino L, Duci M, Fascetti Leon F, Bonadies L, Priante E, Baraldi E, et al. Optimizing nutritional strategies to prevent necrotizing enterocolitis and growth failure after bowel resection. Nutrients. 2021;13(2):340.
pubmed: 33498880
pmcid: 7910892
doi: 10.3390/nu13020340
2023 Manual of Operations, Part 2, Release 27.1 (PDF), Mike Toomey - June 28, 2023 17:05. Available at: https://vtoxford.zendesk.com/hc/en-us/articles/10597055049875-2023-Manual-of-Operations-Part-2-Release-27-1-PDF .
Pierobon ES, Capovilla G, Moletta L, De Pasqual AL, Fornasier C, Salvador R, et al. Multimodal treatment of radiation-induced esophageal cancer: results of a case-matched comparative study from a single center. Int J Surg. 2022;99:106268.
pubmed: 35183734
doi: 10.1016/j.ijsu.2022.106268
Deng BC, Yun YH, Liang YZ. Model population analysis in chemometrics. Chemom Intell Lab Syst. 2015;149:166–76.
doi: 10.1016/j.chemolab.2015.08.018
Stocchero M, De Nardi M, Scarpa B. PLS for classification. Chemom Intell Lab Syst. 2021;216:104374.
doi: 10.1016/j.chemolab.2021.104374
Benjamini Y. Discovering the false discovery rate. J R Stat Soc Series B Stat Methodol. 2010;72(4):405–16.
doi: 10.1111/j.1467-9868.2010.00746.x
Peila C, Sottemano S, Cesare Marincola F, Stocchero M, Pusceddu NG, Dessì A, et al. NMR metabonomic profile of preterm human milk in the first month of lactation: from extreme to moderate prematurity. Foods. 2022;11(3):345.
pubmed: 35159496
pmcid: 8834565
doi: 10.3390/foods11030345
Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics. 1982;38(4):963.
pubmed: 7168798
doi: 10.2307/2529876
Renwick VL, Stewart CJ. Exploring functional metabolites in preterm infants. Acta Paediatr Int J Paediatr. 2022;111:45–53. John Wiley and Sons Inc.
doi: 10.1111/apa.16146
Agakidou E, Agakidis C, Gika H, Sarafidis K. Emerging biomarkers for prediction and early diagnosis of necrotizing enterocolitis in the era of metabolomics and proteomics. Front Pediatr. 2020;8:602255. https://doi.org/10.3389/fped.2020.602255 . Frontiers Media S.A.
Sylvester KG, Ling XB, Liu GYG, Kastenberg ZJ, Ji J, Hu Z, et al. Urine protein biomarkers for the diagnosis and prognosis of necrotizing enterocolitis in infants. J Pediatr. 2014;164(3):607–12.e1–7.
pubmed: 24433829
pmcid: 4161235
doi: 10.1016/j.jpeds.2013.10.091
Sylvester KG, Ling XB, Liu GY, Kastenberg ZJ, Ji J, Hu Z, et al. A novel urine peptide biomarker-based algorithm for the prognosis of necrotising enterocolitis in human infants. Gut. 2014;63(8):1284–92.
pubmed: 24048736
doi: 10.1136/gutjnl-2013-305130
Beck LC, Granger CL, Masi AC, Stewart CJ. Use of omic technologies in early life gastrointestinal health and disease: from bench to bedside. Expert Rev Proteomics. 2021;18:247–59. Taylor and Francis Ltd.
pubmed: 33896313
doi: 10.1080/14789450.2021.1922278
Tricarico P, Crovella S, Celsi F. Mevalonate pathway blockade, mitochondrial dysfunction and autophagy: a possible link. Int J Mol Sci. 2015;16(7):16067–84.
pubmed: 26184189
pmcid: 4519939
doi: 10.3390/ijms160716067
Faulkner R, Jo Y. Synthesis, function, and regulation of sterol and nonsterol isoprenoids. Front Mol Biosci. 2022;9:1006822.
pubmed: 36275615
pmcid: 9579336
doi: 10.3389/fmolb.2022.1006822
Surendran S, Bhatnagar M. Upregulation of N-acetylaspartic acid induces oxidative stress to contribute in disease pathophysiology. Int J Neurosci. 2011;121(6):305–9.
pubmed: 21348802
doi: 10.3109/00207454.2011.558225
Pederzolli CD, Mescka CP, Scapin F, Rockenbach FJ, Sgaravatti ÂM, Sgarbi MB, et al. N-Acetylaspartic acid promotes oxidative stress in cerebral cortex of rats. Int J Dev Neurosci. 2007;25(5):317–24.
pubmed: 17604935
doi: 10.1016/j.ijdevneu.2007.04.002
Pederzolli CD, Rockenbach FJ, Zanin FR, Henn NT, Romagna EC, Sgaravatti ÂM, et al. Intracerebroventricular administration of N-acetylaspartic acid impairs antioxidant defenses and promotes protein oxidation in cerebral cortex of rats. Metab Brain Dis. 2009;24(2):283–98.
pubmed: 19294497
doi: 10.1007/s11011-009-9137-6
Sylvester KG, Kastenberg ZJ, Moss RL, Enns GM, Cowan TM, Shaw GM, et al. Acylcarnitine profiles reflect metabolic vulnerability for necrotizing enterocolitis in newborns born premature. J Pediatr. 2017;181:80–85.e1.
pubmed: 27836286
doi: 10.1016/j.jpeds.2016.10.019
Sinclair TJ, Ye C, Chen Y, Zhang D, Li T, Ling XB, et al. Progressive metabolic dysfunction and nutritional variability precedes necrotizing enterocolitis. Nutrients. 2020;12(5):1275.
pubmed: 32365850
pmcid: 7281969
doi: 10.3390/nu12051275
Lund KC, Scottoline B, Jordan BK. Carnitine-acylcarnitine translocase deficiency masked by extreme prematurity. J Pediatr Genet. 2023;12(02):179–83.
pubmed: 37090833
doi: 10.1055/s-0041-1723960
Diekman EF, Boelen CCA, Prinsen BHCMT, IJlst L, Duran M, de Koning TJ, et al. Necrotizing enterocolitis and respiratory distress syndrome as first clinical presentation of mitochondrial trifunctional protein deficiency. 2012. p. 1–6.
Rusconi B, Warner BB. The hidden treasure of neonatal screening: identifying new risk factors and possible mechanisms of necrotizing enterocolitis through big data. J Pediatr. 2017;181:9–11.
pubmed: 27931825
doi: 10.1016/j.jpeds.2016.11.028
Wandro S, Osborne S, Enriquez C, Bixby C, Arrieta A, Whiteson K. The microbiome and metabolome of preterm infant stool are personalized and not driven by health outcomes, including necrotizing enterocolitis and late-onset sepsis. mSphere. 2018;3(3):10–128.
doi: 10.1128/mSphere.00104-18
Stewart CJ, Nelson A, Treumann A, Skeath T, Cummings SP, Embleton ND, et al. Metabolomic and proteomic analysis of serum from preterm infants with necrotising entercolitis and late-onset sepsis. Pediatr Res. 2016;79(3):425–31.
pubmed: 26571220
doi: 10.1038/pr.2015.235
Stewart CJ, Fatemizadeh R, Parsons P, Lamb CA, Shady DA, Petrosino JF, et al. Using formalin fixed paraffin embedded tissue to characterize the preterm gut microbiota in necrotising enterocolitis and spontaneous isolated perforation using marginal and diseased tissue. BMC Microbiol. 2019;19(1):52.
pubmed: 30832576
pmcid: 6398254
doi: 10.1186/s12866-019-1426-6